About Us
We’ve rebranded some of our products, learn more ›
CODEX® is now PhenoCycler, Phenoptics™ is now Phenolmager.
Explore our history
At Akoya, we believe context is key. Our single-cell imaging solutions phenotype cells with spatial context to visualize how they organize and interact to influence disease progression and treatment response. The PhenoCycler™ (formerly CODEX®) and PhenoImager™ (formerly Phenoptics™) workflows complement each other to provide a comprehensive solution that serves the diverse needs of researchers across discovery, translational and clinical research.
The Spatial Biology Company®
Akoya Biosciences unveils an innovative, integrated suite of solutions to enable unbiased spatial phenotyping at unprecedented speeds, setting a new standard in spatial biology.
Akoya Biosciences Acquires Phenoptics
Akoya Biosciences acquires the Phenoptics portfolio from PerkinElmer® to establish a combined portfolio of complementary technologies
Akoya Biosciences is Founded
Akoya Biosciences was founded to commercialize the CODEX® technology, developed in the lab of Dr. Garry Nolan at Stanford University, to enable ultrahigh multiplexed analysis for biomarker discovery.
PerkinElmer Acquires Caliper Life Sciences
The Phenoptics™ portfolio, based on MSI technology, becomes the industry standard for multiplexed tissue analysis in translational research.
Cambridge Research & Instrumentation (CRI)
CRI is co-founded by Peter Miller and Cliff Hoyt to commercialize revolutionary Multispectral Imaging (MSI) technology. CRI is acquired by Caliper Life Sciences in 2010 to accelerate MSI development for tissue biomarker analysis
Akoya is excited to bring unprecedented power, scale, and automation to histology and single-cell analysis through our multiplex immunofluorescence solutions. With both the PhenoImager and PhenoCycler portfolios, we provide our customers with a full suite of end-to-end solutions for high parameter tissue analysis.
